Section B Flashcards
pharmacokinetics
effects of the body on the drug or fate of the drug in the body
pharmacodynamics
effects of the drug on the body
what are the various methods of administering drugs?
enteral, topical, parenteral
list 4 examples of enteral drug administration
oral, nasogastric, gastronomy, buccal/sublingual
list 4 examples of topical drug administration
skin, eyes/ears/nose, inhalation, rectal/vaginal
list 7 examples of parenteral drug administration
intravenous, intramuscular, subcutaneous, intradermal, intrathecal, epidural, intra-articular
bioavailability
the fraction of the drug administered that reaches the systemic circulation
first pass metabolism
orally, some of the drug is metabolized (inactivated) before entering circulation
enzyme induction and its clinical relevance
increase in drug metabolizing enzyme activity caused by a foreign compound (inducer)
- requires prolonged exposure to inducer
- causes accelerated clearance, reduced drug action and increased formation of toxic metabolites
can cause drugs to be less effective due to rapid clearance
enzyme inhibition and its clinical relevance
decrease in enzyme activity caused by a foreign compound
- requires only single dose
- causes impaired clearance and prolonged action
can cause therapeutic levels to rise to toxic levels in drugs with small therapeutic ratios due to prolonged clearance
half-life
time it takes to eliminate half of a drug from the circulation
affinity
attractive forces between the drug and the receptor (causes drug to bind to receptor)
efficacy
ability of the drug when bound to initiate change
potency
measure of the drug at which it is effective
specificity
ability of the receptor to recognize specific chemical configurations
agonists
bind to receptors, cause conformational change, result in a response
antagonists
bind to receptors, don not cause conformational change, no activation, no efficacy, blocks agonists from binding
partial agonists
bind to receptor, but do not elicit maximal response, must occupy a large number of receptors to elicit a response
why are elderly patients more at risk for ADRs? (8)
- multiple illness
- multiple medications
- altered homeostasis
- altered immunity
- altered pharmacokinetics
- altered pharmacodynamics
- sensitivity to sedatives
- compliance problems
why are people with liver disease more at risk for ADRs? (5)
- encephalopathy risk (sedatives/diuretics)
- clotting factor synthesis not normal -> bleeding
- low protein affects drug binding and fluid balance
- metabolism abnormal -> potential for toxicity
- shunting affects bioavailability
why are people with renal disease more at risk for ADRs? (5)
- failure to excrete drugs
- failure to excrete metabolites
- increased sensitivity to drugs
- side-effects are poorly tolerated
- some drugs may be ineffective